Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus

Background Impaired diastolic heart function has been observed in persons with non-alcoholic fatty liver disease (NAFLD) and/or with type 2 diabetes mellitus (T2DM). However, it is unclear whether NAFLD fibrotic progression, i.e., non-alcoholic steatohepatitis, poses an independent risk for diastolic dysfunction in T2DM. We investigated the association between liver fibrosis and left ventricular (LV) diastolic dysfunction in T2DM. Methods We analyzed 606 patients with T2DM, aged ≥50 years, who had undergone liver ultrasonography and pulsed-wave Doppler echocardiography. Insulin sensitivity was measured by short insulin tolerance test. Presence of NAFLD and/or advanced liver fibrosis was determined by abdominal ultrasonography and NAFLD fibrosis score (NFS). LV diastolic dysfunction was defined according to transmitral peak early to late ventricular filling (E/A) ratio and deceleration time, using echocardiography. Results LV diastolic dysfunction was significantly more prevalent in the NAFLD versus non-NAFLD group (59.7% vs. 49.0%, P=0.011). When NAFLD was stratified by NFS, subjects with advanced liver fibrosis exhibited a higher prevalence of diastolic dysfunction (49.0%, 50.7%, 61.8%; none, simple steatosis, advanced fibrosis, respectively; P for trend=0.003). In multivariable logistic regression, liver fibrosis was independently associated with diastolic dysfunction (odds ratio [OR], 1.58; 95% confidence interval [CI], 1.07 to 2.34; P=0.022) after adjusting for insulin resistance and cardiometabolic risk factors. This association remained significant in patients without insulin resistance (OR, 4.32; 95% CI, 1.73 to 11.51; P=0.002). Conclusions Liver fibrosis was associated with LV diastolic dysfunction in patients with T2DM and may be an independent risk factor for diastolic dysfunction, especially in patients without systemic insulin resistance.

[1]  Enrico Barbieri,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes , 2012, Diabetes Care.

[2]  S. Park,et al.  Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. , 2014, The Journal of clinical endocrinology and metabolism.

[3]  William T. Clarke,et al.  Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes , 2016, Journal of the American College of Cardiology.

[4]  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.

[5]  S. Malnick,et al.  Non-alcoholic fatty liver disease - the heart of the matter. , 2015, World journal of hepatology.

[6]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[7]  P. Rattanawong,et al.  Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis , 2017, European journal of gastroenterology & hepatology.

[8]  Mats Fredrikson,et al.  Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[9]  E. Bonora,et al.  Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes , 2015, PloS one.

[10]  G. MacGowan,et al.  Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control , 2015, Cardiovascular Diabetology.

[11]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[12]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[13]  Sanjiv J. Shah,et al.  Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study , 2015, Hepatology.

[14]  B. Howard,et al.  Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults: The Strong Heart Study , 2002, Circulation.

[15]  S. Goland,et al.  Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment , 2006, Journal of clinical gastroenterology.

[16]  E. Han,et al.  Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases , 2017, Diabetes & metabolism journal.

[17]  E. Kang,et al.  Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. , 2017, Journal of hepatology.

[18]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.

[19]  Tolga Yakar,et al.  Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. , 2010, Cardiology journal.

[20]  V. Wong,et al.  NAFLD in Asia—as common and important as in the West , 2013, Nature Reviews Gastroenterology &Hepatology.

[21]  G. Cho,et al.  Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population , 2014, Heart.

[22]  James B Seward,et al.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.

[23]  A. Nicolini,et al.  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt , 2006, Gut.

[24]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings , 2002, Circulation.

[25]  R. Farah,et al.  Presence of coronary plaques in patients with nonalcoholic fatty liver disease. , 2010, Radiology.

[26]  H. Hense,et al.  Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. , 2003, European heart journal.

[27]  Herbert Tilg,et al.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases , 2017, Gut.

[28]  M. Watt,et al.  Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance , 2017, Nature Reviews Endocrinology.

[29]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[30]  C. Zancanaro,et al.  Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. , 1989, The Journal of clinical endocrinology and metabolism.

[31]  G. Habib,et al.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. , 2002, Circulation.

[32]  P. Poirier,et al.  Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. , 2001, Diabetes care.

[33]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[34]  G. Lopaschuk,et al.  Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. , 2012, American journal of physiology. Endocrinology and metabolism.

[35]  P. Scifo,et al.  Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver , 2007, Hepatology.

[36]  Casper G. Schalkwijk,et al.  Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008 .

[37]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[38]  J. Sowers,et al.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy , 2016, Nature Reviews Endocrinology.

[39]  G. Marchesini,et al.  Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. , 2015, Journal of hepatology.

[40]  E. Kang,et al.  Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes , 2015, Cardiovascular Diabetology.

[41]  Z. Younossi,et al.  Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. , 2008, Journal of hepatology.

[42]  R. Chung,et al.  Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction , 2017, Obesity.

[43]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction , 2002 .